Table 1.
Study characteristics.
| Source |
N (Int/Con) |
Relation to patients |
Age (M/SD) |
Cancer type | Intervention | Control group | Follow-up | Measurement tools |
|---|---|---|---|---|---|---|---|---|
| Bultz et al. (17) | 34 (17/17) |
Spouse | 51 | Breast | CBT 6 weeks | No intervention |
3 months | POMS,IM SFSSS |
| Kuijer et al. (18) | 59 (32/27) |
Spouse | Nil | Breast, intestinal, Hodgkin, brain, lung |
CBT | No intervention |
3 months | CES-D |
| Hudson et al. (19) | 106 (54/52) |
Spouse, parent, child | 60.78 (13.98) |
Unspecified/ advanced |
Psycho educational intervention: |
Standard care | Nil | HADS |
| Given et al. (20) | 237 (118/119) |
Spouse and others | 55.3 (13.76) |
Unspecified/67% advanced |
CBT | No intervention | 10 weeks | CES-D |
| Carter et al. (21) | 34 (16/18) |
Spouse and children | 53 (17) |
Unspecified/advanced | Caregiver sleep intervention |
No intervention | 2\3\4 months |
PSQI,CES-D CQOL-C |
| Badger et al. (22) | 71 (36/35) |
Partner | 61.13 (10.9) |
Prostate | Dyadic telephone counseling |
Routine health education | 8\16 weeks |
CES-D PANAS,MFI |
| Meyers et al. (23) | 476 (348/128) |
Spouse, children, and others |
61.4 | Gastrointestinal, genitourinary, and thoracic |
Paired home care guide | No intervention | 30\90\120 \180\days |
CHO-QOL SPSI-R |
| Fegg et al. (24) | 133 (81/79) |
Spouse, parent, and others |
54.3 (13.2) |
Gynecologic al tumor, lung, breast, and Brain tumor | Existential behavioral therapy | No intervention | 3\12 months |
BSI,EF WHOQOL-BR |
| Han et al. (25) | 309 (154/155) |
Spouse, children, and sibling |
Nil | Unspecified | CBT | No intervention | Nil | SF-36 CQOL-C |
| Clark et al. (26) | 131 (65/66) |
Nil | 58.7 (10.6) |
Gastrointestinal, brain, head, neck, lung, and other |
Paired structured CBT training | No intervention | 4\27 weeks |
CQOL-C |
| Dionne-Odom et al. (27) | 124 (63/61) |
Nil | 60 | Palliative care | Telephone grief counseling |
No intervention | 3 months |
CQOL-C CES-D |
| Borji et al. (28) | 80 (40/40) |
Spouse, adult, other | Nil | Prostate | CBT | No intervention | 8 weeks |
DASS-21 |
| Wu et al. (29) | 60 (30/30) |
Nil | Nil | Terminal stage | Psychological suggestion |
No intervention | Nil | HAMD HAMA |
| Yue-cai et al. (30) | 120 (60/60) |
Nil | 57.2 | Oropharyngeal | CBT | General care |
Nil | WHOQOL-100 |
| Kubo et al. (31) | 31 (17/14) |
Spouse, child, other relatives, friend | Nil | Breast, hematologic, skin, lung, gastrointestinal, head, neck, genitourinary, and other |
Mindfulness-based program |
No intervention | Nil | HADS CQOL-C |
| Xiu et al. (32) | 157 (81/76) |
Family members | 53.9 (12.18) |
Lung | CBT | I-BMS | 8\12 weeks | CQOL-C HADS, ISI |
| Trevino et al. (33) | 26 (12/14) |
Spouse, other | 64.24 (16.74) |
Lung, gynecologic, breast, colorectal, lymphoma, genitourinary, and pancreatic. |
Managing anxiety from cancer | No intervention | Nil | HADS caregiver quality of life–cancer scale |
Con, control group; Int, intervention group; POMS, the profile of mood states; IMS, the index of marital satisfaction; FSSS, the DUKE-UNC functional social support scale; CES-D, the center of epidemiological studies depression scale; HADS, the hospital anxiety and depression scale; PSQI, the Pittsburgh sleep quality index; CQOL-C, the caregiver quality of life index-cancer; PANAS, the positive and negative affect schedule; MFI, the 20-item multidimensional fatigue inventory; COH-QOL, the city of hope quality of life; SPSI-R, social problem-solving inventory-revised; BSI, the brief symptom inventory; WHOQOL, World Health Organization quality of life measurement scale; SF-36, MOS 36-item short-form health survey; DASS-21, the 21-item depression anxiety stress scales; HAMD, Hamilton depression scale; HAMA, Hamilton anxiety rating scale; ISI, 7-item insomnia severity index (see Appendix for a brief description of the scale).